We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CNVVY market cap is 7.15B. The company's latest EPS is USD 0.3717 and P/E is 6.92.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.89B | 2.04B | 2.07B | 2.14B | 2.29B |
| Operating Income | 210.9M | 203.6M | 207.3M | 262.7M | 324.9M |
| Net Income | 112.5M | 117.6M | 62.9M | 130.3M | 190.5M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.77B | 3.67B | 3.59B | 3.71B | 3.52B |
| Total Liabilities | 2.1B | 1.98B | 1.98B | 2.02B | 1.83B |
| Total Equity | 1.67B | 1.69B | 1.61B | 1.69B | 1.69B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 399.5M | 305.9M | 281.7M | 367.4M | 396.2M |
| Investing | -56.3M | -206.5M | -348.3M | -285.7M | -160.8M |
| Financing | -162.1M | -199.9M | -237.1M | -124M | -263.8M |
| Market Cap | 7.15B |
| Price to Earnings Ratio | 6.92 |
| Price to Sales Ratio | 0.58 |
| Price to Cash Ratio | 20.38 |
| Price to Book Ratio | 0.78 |
| Dividend Yield | 1.74% |
| Shares Outstanding | 512.45M |
| Average Volume (1 week) | 5.45k |
| Average Volume (1 Month) | 8.36k |
| 52 Week Change | -2.91% |
| 52 Week High | 14.50 |
| 52 Week Low | 10.77 |
| Spread (Intraday) | 1.35 (9.35%) |
| Company Name | ConvaTec Group PLC (PK) |
| Address |
3 forbury place reading RG1 3JH |
| Website | https://www.convatec.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
